Related Experiment Video
Updated: Aug 11, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Percutaneous treatment of deep vein thrombosis in May-Thurner syndrome
Jong-Youn Kim1, Donghoon Choi, Young Guk Ko
1Cardiology Division, Yonsei Cardiovascular Center and Cardiovascular Research Institute, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul 120-752, Korea.
Insights
May-Thurner syndrome, a condition causing deep vein thrombosis, can be effectively treated with endovascular methods. Catheter-guided thrombolysis and stenting offer a safe and successful approach for patients with this venous compression disorder.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Cardiovascular Medicine
Background:
- May-Thurner syndrome involves compression of the left common iliac vein by the right common iliac artery.
- This compression can lead to deep vein thrombosis (DVT) and chronic venous insufficiency.
- Endovascular techniques are increasingly utilized for managing complex venous pathologies.
Purpose of the Study:
- To evaluate the efficacy and safety of endovascular treatment for May-Thurner syndrome.
- To assess outcomes of catheter-guided thrombolysis, angioplasty, and stenting in patients with iliofemoral DVT.
- To report clinical experience with these minimally invasive interventions.
Main Methods:
- A cohort of 21 patients diagnosed with May-Thurner syndrome via venogram was studied.
- Eighteen patients underwent catheter-guided thrombolysis followed by balloon angioplasty and/or stent placement.
- Three patients with limited venous involvement were treated without thrombolysis.
Main Results:
- Initial technical success with symptom resolution was achieved in 95% (20/21) of patients.
- Mean follow-up was 10.8 months; recurrent thrombosis occurred in 2 patients with stents and 3 without.
- One patient experienced a major bleeding complication (retroperitoneal hematoma); overall safety was high.
Conclusions:
- Catheter-guided thrombolysis combined with angioplasty and stent implantation is a safe and effective treatment for May-Thurner syndrome.
- Endovascular management provides high initial success rates for extensive iliofemoral DVT caused by this syndrome.
- Stenting appears crucial for preventing recurrence in May-Thurner syndrome patients treated endovascularly.
Background/Purpose:
May-Thurner syndrome is an uncommon disease entity in which the left common iliac vein is compressed by the right common iliac artery with subsequent development of deep vein thrombosis and chronic venous insufficiency. We report our experience on the treatment of extensive iliofemoral deep venous thrombosis due to May-Thurner syndrome using endovascular techniques.
Methods:
The study group comprised 21 patients (8 men, 13 women; mean age 51 years) diagnosed with May-Thurner syndrome by venogram. Eighteen patients were treated with catheter-guided thrombolysis; 3 patients with short segment involvement did not require thrombolysis. After completion of the thrombolytic therapy, the residual venous narrowing was treated by balloon angioplasty and/or placement of a self-expandable stent.
Results:
The mean total dose of urokinase was 4.28 +/- 1.89 million units, and the mean duration of infusion was 72 +/- 35 hr. Eighteen of the 21 patients received stent deployment. The mean diameter of the stents was 12.9 +/- 2.0 mm. Initial technical successes with immediate symptom resolution were achieved in 20 of the 21 patients (95%). We performed a follow-up venogram 6 months after procedure and checked clinical symptoms at outpatient clinics (mean follow-up duration 10.8 months). Among the patients who received stent implantation, 2 had recurrent thrombotic occlusion during the follow-up period. Three patients, who did not receive stent implantation, all had recurrent thrombosis. There were no major bleeding complications except in 1 patient who developed retroperitoneal hematoma.
Conclusion:
Catheter-guided thrombolysis and angioplasty with stent implantation is a safe and effective method for the treatment of May-Thurner syndrome.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management

